Similar articles

• Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?

  Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U. Piorkowski M, et al. J Am Coll Cardiol. 2007 Mar 13;49(10):1035-42. doi: 10.1016/j.jacc.2006.10.064. Epub 2007 Feb 23. J Am Coll Cardiol. 2007. PMID: 17349882 Clinical Trial.
• [Hyperlipidemia: decreasing lipid values and effects of statins].

  Mathes P. Mathes P. Z Kardiol. 2002;91 Suppl 2:25-9. Z Kardiol. 2002. PMID: 12436762 Review. German. No abstract available.
• [Why the decrease of cholesterol has stopped, although use of statins is increasing?].

  Vartiainen E. Vartiainen E. Duodecim. 2005;121(22):2373-4. Duodecim. 2005. PMID: 16457069 Finnish. No abstract available.
• The safety of statins in children.

  Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V. Lamaida N, et al. Acta Paediatr. 2013 Sep;102(9):857-62. doi: 10.1111/apa.12280. Epub 2013 May 15. Acta Paediatr. 2013. PMID: 23631461 Review.
• Low-density lipoprotein cholesterol-independent effects of statins on coronary artery disease.

  Takagi H, Umemoto T. Takagi H, et al. Am J Cardiol. 2011 Jan 15;107(2):336. doi: 10.1016/j.amjcard.2010.10.002. Am J Cardiol. 2011. PMID: 21211613 No abstract available.